Tanomastat

Tanomastat

CAT N°: 19258
Price:

From 55.00 46.75

Tanomastat is an inhibitor of matrix metalloproteinase-2 (MMP-2), MMP-3, and MMP-9 (Kis = 11, 143, and 301 nM, respectively).{23056} It is selective for MMP-2, -3, and -9 over MMP-1 and MMP-13 (Kis = 5,000 and 1,470 nM, respectively). Tanomastat (15 µM) inhibits VEGF- and FGF-induced tubule formation in human umbilical vein endothelial cells (HUVECs).{58870} It reduces tumor growth and the number of pulmonary metastases in an MDA-MB-435 orthotopic mouse model of breast cancer when administered at a dose of 100 mg/kg. Tanomastat (50 mg/kg) decreases disease severity in a rat model of adjuvant-induced arthritis.{58871}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • 4′-chloro-?-oxo-?S-[(phenylthio)methyl]-[1,1′-biphenyl]-4-butanoic acid
  • Correlated keywords
    • 215258-80-3 878799-38-3 BAY12-9566 BAY129566 BAY 129566 matrix metalloproteinase MMP-2 MMP-3 MMP-9 anticancer anti-cancer metastasis MMP2 MMP3 MMP9
  • Product Overview:
    Tanomastat is an inhibitor of matrix metalloproteinase-2 (MMP-2), MMP-3, and MMP-9 (Kis = 11, 143, and 301 nM, respectively).{23056} It is selective for MMP-2, -3, and -9 over MMP-1 and MMP-13 (Kis = 5,000 and 1,470 nM, respectively). Tanomastat (15 µM) inhibits VEGF- and FGF-induced tubule formation in human umbilical vein endothelial cells (HUVECs).{58870} It reduces tumor growth and the number of pulmonary metastases in an MDA-MB-435 orthotopic mouse model of breast cancer when administered at a dose of 100 mg/kg. Tanomastat (50 mg/kg) decreases disease severity in a rat model of adjuvant-induced arthritis.{58871}

We also advise you